Franceschi Nika, Gašić Ana, Šitum Mirna, Majda Vučić, Kolić Maja
Nika Franceschi, MD, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia;
Acta Dermatovenerol Croat. 2022 Nov;30(3):201-202.
Darier disease (DD), also known as Darier-White disease, follicular keratosis, or dyskeratosis follicularis, is an uncommon autosomal dominant genodermatosis with complete penetrance and variable expressivity. This disorder is caused by mutations in the ATP2A2 gene and affects the skin, nails, and mucous membranes (1,2). A 40-year-old woman, without comorbidities, presented with pruritic, unilateral skin lesions on the trunk since she was 37 years old. Lesions had remained stable since onset, with physical examination revealing tiny scattered erythematous to light brown keratotic papules beginning at the patient's abdominal midline, extending over her left flank and onto her back (Figure 1, a, b). No other lesions were observed, and family history was negative. Skin punch biopsy revealed parakeratotic and acanthotic epidermis with foci of suprabasilar acantholysis and corps ronds in the stratum spinosum (Figure 2, a, b, c). Based on these findings, the patient was diagnosed with segmental DD - localized form type 1. DD usually develops between the ages of 6 and 20 and is characterized by keratotic, red to brown, sometimes yellowish, crusted, pruritic papules in a seborrheic distribution (3,4). Nail abnormalities, alternating red and/or white longitudinal bands, fragility, and subungual keratosis can be present. Mucosal whitish papules and palmoplantar keratotic papules are also frequently observed. Insufficient function of the ATP2A2 gene that encodes for the sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA2) leads to calcium dyshomeostasis, loss of cellular adhesion, and characteristic histological findings of acantholysis and dyskeratosis. The main pathological finding is the presence of two types of dyskeratotic cells, "corps ronds", present in the Malpighian layer, and "grains", mostly located in the stratum corneum (1). Approximately 10% of cases present as the localized form of disease, with two phenotypes of segmental DD having been observed. The more common, type 1, is characterized by a unilateral distribution along Blaschko's lines with normal surrounding skin, whereas the type 2 variant presents with generalized disease and localized areas of increased severity. Although generalized DD is associated with nail and mucosal involvement, as well as positive family history, these findings are rarely seen in localized forms (1). Family members with identical ATP2A2 mutations may have notable differences in clinical manifestations of the disease (5). DD is usually a chronic disease with reccurent exacerbations. Exacerbating factors include sun exposure, heat, sweat, and occlusion (2). Infection is a common complication (1). Associated conditions include neuropsychiatric abnormalities and squamous cell carcinoma (6,7). Increased risk of heart failure has also been observed (8). Type 1 segmental DD may be clinically and histologically hard to distinguish from acantholytic dyskeratotic epidermal nevus (ADEN). Age of onset plays an important role in differentiation, as ADEN is often congenital (3). However, some studies suggest ADEN is a localized form of DD (1). Other differential diagnoses include herpes zoster, lichen striatus, lichen planus (4), severe seborrheic dermatitis, and Grover disease. Our patient was treated with a topical retinoid, for the first two weeks in combination with a topical corticosteroid. She was advised on the use of proper daily skincare with antimicrobial cleansers and emollients, as well as behavioral measures such as avoiding triggering factors and wearing light clothing, resulting in substantial clinical improvement (Figure 1, c, d) and amelioration of pruritus. Other treatment options include salicylic and lactic acid as well as topical 5-fluorouracil, while oral retinoids are reserved for more severe disease (1-3). Doxycycline and pulsed dye laser have also been reported to be effective (2,9). One in vitro study showed that COX-2 inhibitors may reinstitute the dysregulated ATP2A2 gene (4). In summary, DD is a rare keratinization disorder that can present in a generalized or localized pattern. Although uncommon, segmental DD should be included in the differential diagnosis of dermatoses that follow Blaschko's lines. Treatment options include various topical and oral treatments, depending on disease severity.
达里埃病(DD),也称为达里埃 - 怀特病、毛囊角化病或毛囊性角化不良,是一种罕见的常染色体显性遗传性皮肤病,具有完全外显率和可变表达性。这种疾病由ATP2A2基因突变引起,会影响皮肤、指甲和黏膜(1,2)。一名40岁无合并症的女性,自37岁起躯干出现瘙痒性单侧皮肤病变。病变自发病以来一直稳定,体格检查发现从患者腹部中线开始有微小的散在红斑至浅褐色角化丘疹,延伸至左侧胁腹并蔓延到背部(图1,a,b)。未观察到其他病变,家族史为阴性。皮肤穿刺活检显示角化不全和棘层肥厚的表皮,棘层上部有棘层松解灶和棘突松解性角化不良小体(图2,a,b,c)。基于这些发现,该患者被诊断为节段性DD - 局限型1型。DD通常在6至20岁之间发病,其特征为脂溢性分布的角化性、红色至褐色、有时呈黄色、结痂、瘙痒性丘疹(3,4)。可能存在指甲异常,如交替出现的红色和/或白色纵纹、易碎性和甲下角化。黏膜白色丘疹和掌跖角化丘疹也经常可见。编码肌浆网/内质网钙ATP酶2型(SERCA2)的ATP2A2基因功能不足会导致钙稳态失调、细胞黏附丧失以及棘层松解和角化不良的特征性组织学表现。主要病理发现是存在两种角化不良细胞,“棘突松解性角化不良小体”存在于马尔皮基层,“颗粒”大多位于角质层(1)。约10%的病例表现为疾病的局限型,已观察到节段性DD的两种表型。较常见的1型,其特征是沿布拉斯科线单侧分布,周围皮肤正常,而2型变异型表现为全身性疾病且有局部严重程度增加的区域。虽然全身性DD与指甲和黏膜受累以及阳性家族史相关,但这些表现很少见于局限型(1)。具有相同ATP2A2突变的家庭成员在该疾病的临床表现上可能有显著差异(5)。DD通常是一种慢性疾病,会反复发作。加重因素包括日晒、热、出汗和闭塞(2)。感染是常见的并发症(1)。相关疾病包括神经精神异常和鳞状细胞癌(6,7)。还观察到心力衰竭风险增加(8)。1型节段性DD在临床和组织学上可能难以与棘层松解性角化不良性表皮痣(ADEN)区分。发病年龄在鉴别中起重要作用,因为ADEN通常是先天性的(3)。然而,一些研究表明ADEN是DD的一种局限型(1)。其他鉴别诊断包括带状疱疹、线状苔藓、扁平苔藓(4)、重度脂溢性皮炎和格罗弗病。我们的患者接受了外用维甲酸治疗,前两周联合外用糖皮质激素。建议她使用合适的日常护肤品,包括抗菌清洁剂和润肤剂,以及采取行为措施,如避免触发因素和穿轻薄衣物,从而使临床症状得到显著改善(图1,c,d)并减轻了瘙痒。其他治疗选择包括水杨酸和乳酸以及外用5 - 氟尿嘧啶,而口服维甲酸则用于更严重的疾病(1 - 3)。据报道,多西环素和脉冲染料激光也有效(2,9)。一项体外研究表明,COX - 2抑制剂可能恢复失调的ATP2A2基因功能(4)。总之,DD是一种罕见的角化障碍性疾病,可呈全身性或局限型表现。虽然不常见,但节段性DD应纳入沿布拉斯科线分布的皮肤病的鉴别诊断中。治疗选择包括各种外用和口服治疗,具体取决于疾病严重程度。